BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8471424)

  • 1. Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.
    De Giovanni C; Lollini PL; Dolcetti R; Landuzzi L; Nicoletti G; D'Andrea E; Scotland K; Nanni P
    Br J Cancer; 1993 Apr; 67(4):674-9. PubMed ID: 8471424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological, biochemical, and molecular biological characterization of a rat rhabdomyosarcoma cell line during differentiation induction in vitro.
    Gerharz CD; Doehmer J; Mayer H; Oesch F; Gabbert H
    Environ Health Perspect; 1990 Aug; 88():187-91. PubMed ID: 2272313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differentiation induction in the human rhabdomyosarcoma cell line TE-671. A morphological, biochemical and molecular analysis.
    Ramp U; Gerharz CD; Engers R; Marx N; Gabbert HE
    Anticancer Res; 1995; 15(1):181-8. PubMed ID: 7733631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T; Okabe-Kado J; Hozumi M; Honma Y
    Cancer Res; 1994 Jan; 54(2):592-7. PubMed ID: 8275499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N,N-Dimethylformamide-induced morphological differentiation and reduction of tumorigenicity in cultured mouse rhabdomyosarcoma cells.
    Dexter DL
    Cancer Res; 1977 Sep; 37(9):3136-40. PubMed ID: 195720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
    Gogusev J; Barbey S; Nezelof C
    Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.
    Nicoletti G; De Giovanni C; Landuzzi L; Simone G; Rocchi P; Nanni P; Lollini PL
    Br J Cancer; 1992 Apr; 65(4):519-22. PubMed ID: 1562460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in proto-oncogene raf expression precedes differentiation induction in different clonal rhabdomyosarcoma subpopulations.
    Ramp U; Gerharz CD; Doehmer J; Oster O; Gabbert HE
    Anticancer Res; 1992; 12(2):537-46. PubMed ID: 1316093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uniform response of c-raf expression to differentiation induction and inhibition of proliferation in a rat rhabdomyosarcoma cell line.
    Ramp U; Gerharz CD; Doehmer J; Oster O; Gabbert HE
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1990; 59(5):271-80. PubMed ID: 1980557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced expression of the proto-oncogenes fos and raf in the rhabdomyosarcoma cell line BA-HAN-1C after differentiation induction with retinoic acid and N-methylformamide.
    Gabbert HE; Gerharz CD; Ramp U; Hoffmann J; Oster O; Oesch F; Doehmer J
    Int J Cancer; 1990 Apr; 45(4):724-30. PubMed ID: 2108933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells.
    Astolfi A; De Giovanni C; Landuzzi L; Nicoletti G; Ricci C; Croci S; Scopece L; Nanni P; Lollini PL
    Gene; 2001 Aug; 274(1-2):139-49. PubMed ID: 11675006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dexamethasone on induction of monocytic differentiation in human U-937 cells by dimethylsulfoxide.
    Nakamura T; Kharbanda S; Spriggs D; Kufe D
    J Cell Physiol; 1990 Feb; 142(2):261-7. PubMed ID: 2406276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transcriptional control of c-myc proto-oncogene expression by glucocorticoid hormones in human T lymphoblastic leukemic cells.
    Maroder M; Martinotti S; Vacca A; Screpanti I; Petrangeli E; Frati L; Gulino A
    Nucleic Acids Res; 1990 Mar; 18(5):1153-7. PubMed ID: 2320412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of memory, differentiation, and repression of c-myc and p53 genes in human RD/TE-671 cells induced by a ureido-derivative of pyridine (UDP-4).
    Pappas IS; Sophianos D; Tzartos S; Tsiftsoglou AS
    Cell Growth Differ; 1996 Jun; 7(6):797-809. PubMed ID: 8780893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid effect on oncogene/growth gene expression in human T lymphoblastic leukemic cell line CCRF-CEM. Specific c-myc mRNA suppression by dexamethasone.
    Yuh YS; Thompson EB
    J Biol Chem; 1989 Jun; 264(18):10904-10. PubMed ID: 2659598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actinomycin D treatment leads to differentiation and inhibits proliferation in rhabdomyosarcoma cells.
    Marchal JA; Prados J; Melguizo C; Fernández JE; Vélez C; Alvarez L; Aránega A
    J Lab Clin Med; 1997 Jul; 130(1):42-50. PubMed ID: 9242365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid modulation of transformed cell proliferation is oncogene specific and correlates with effects on c-myc levels.
    O'Banion MK; Levenson RM; Brinckmann UG; Young DA
    Mol Endocrinol; 1992 Sep; 6(9):1371-80. PubMed ID: 1331773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1).
    Hass R; Brach M; Kharbanda S; Giese G; Traub P; Kufe D
    J Cell Physiol; 1991 Oct; 149(1):125-31. PubMed ID: 1939341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP effects on myogenic gene expression in rhabdomyosarcoma cells.
    Wasserman LM; Newsham I; Huang HJ; Cavenee WK
    Exp Cell Res; 1996 Aug; 227(1):55-62. PubMed ID: 8806451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.